Legal & General Group
RVMD icon

Legal & General Group’s Revolution Medicines RVMD Stock Holding History

Legal & General Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.4M Buy
381,366
+40,218
+12% +$5.87M 0.01% 576
2026
Q1 		$33.2M Buy
341,148
+187,768
+122% +$19M 0.01% 690
2025
Q4 		$12.2M Sell
153,380
-2,009
-1% -$132K ﹤0.01% 1059
2025
Q3 		$7.26M Sell
155,389
-7,444
-5% -$291K ﹤0.01% 1371
2025
Q2 		$5.99M Sell
162,833
-3,905
-2% -$150K ﹤0.01% 1463
2025
Q1 		$5.9M Buy
166,738
+36,080
+28% +$1.46M ﹤0.01% 1444
2024
Q4 		$5.71M Buy
130,658
+8,660
+7% +$437K ﹤0.01% 1516
2024
Q3 		$5.53M Buy
121,998
+2,066
+2% +$90K ﹤0.01% 1532
2024
Q2 		$4.65M Buy
119,932
+13,803
+13% +$516K ﹤0.01% 1560
2024
Q1 		$3.42M Sell
106,129
-2,553
-2% -$75.7K ﹤0.01% 1701
2023
Q4 		$3.12M Buy
108,682
+32,235
+42% +$775K ﹤0.01% 1735
2023
Q3 		$2.12M Buy
76,447
+1,575
+2% +$46.7K ﹤0.01% 1876
2023
Q2 		$2M Sell
74,872
-911
-1% -$22.4K ﹤0.01% 1933
2023
Q1 		$1.64M Buy
75,783
+13,051
+21% +$321K ﹤0.01% 1969
2022
Q4 		$1.49M Buy
62,732
+9,733
+18% +$207K ﹤0.01% 2002
2022
Q3 		$1.04M Buy
52,999
+8,691
+20% +$191K ﹤0.01% 2128
2022
Q2 		$863K Buy
44,308
+449
+1% +$8.74K ﹤0.01% 2211
2022
Q1 		$1.12M Buy
43,859
+788
+2% +$17.2K ﹤0.01% 2209
2021
Q4 		$1.08M Hold
43,071
– – ﹤0.01% 2215
2021
Q3 		$1.19M Buy
43,071
+9,272
+27% +$270K ﹤0.01% 2198
2021
Q2 		$1.07M Buy
33,799
+9,478
+39% +$331K ﹤0.01% 2194
2021
Q1 		$1.12M Buy
24,321
+19,117
+367% +$857K ﹤0.01% 2166
2020
Q4 		$206K Sell
5,204
-728
-12% -$28.8K ﹤0.01% 2414
2020
Q3 		$206K Buy
5,932
+2,971
+100% +$82.3K ﹤0.01% 2353
2020
Q2 		$94K Sell
2,961
-17,794
-86% -$559K ﹤0.01% 2551
2020
Q1 		$453K Buy
+20,755
New +$575K ﹤0.01% 2096

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Legal & General Group's RVMD Position: Q2 2026 in Review

Legal & General Group increased its Revolution Medicines (RVMD) stake by 12% in Q2 2026, buying an estimated $5.87M and bringing the position to 381,366 shares worth $71.4M. The position accounts for 0.01% of the portfolio, ranked #576.

Legal & General Group first reported a position in RVMD in Q1 2020 and has held it in 26 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Legal & General Group held 381,366 shares of Revolution Medicines worth $71.4M as of Q2 2026.
  • Legal & General Group bought 40,218 Revolution Medicines shares in Q2 2026, an estimated $5.87M.
  • Revolution Medicines made up 0.01% of Legal & General Group's portfolio in Q2 2026, its #576 holding.
  • Legal & General Group first reported a position in Revolution Medicines in Q1 2020 and has held it in 26 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.